Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Ikarian Capital »

Galecto shares owned by Ikarian Capital

Quarter-by-quarter ownership of Galecto (GLTO) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Galecto

Tip: Access up to 7 years of quarterly data

All positions including Galecto held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download consolidated filings csv

Download as Excel

Download consolidated filings xlsx

Quarterly reported holdings in Galecto by Ikarian Capital

Quarter filed	Position value	Share count	Share price at filing
2025-12-31	$6.6M	286k	23.01

More positions owned by Ikarian Capital

Cidara Therapeutics Com New (CDTX)

Spdr Series Trust State Street Spd Put Option (XBI)

Terns Pharmaceuticals (TERN)

Abivax Sa Sponsored Ads (ABVX)

Harrow Health (HROW)

Rapt Therapeutics Com New (RAPT)

Cytokinetics Com New (CYTK)

Jazz Pharmaceuticals Call Call Option

Soleno Therapeutics (SLNO)

Jazz Pharmaceuticals Shs Usd (JAZZ)

Maze Therapeatics (MAZE)

Omeros Corporation Call Option (OMER)

Praxis Precision Medicines I Com New (PRAX)

Olema Pharmaceuticals (OLMA)

View all positions for Ikarian Capital

Top funds holding Galecto

Ikarian Capital

Point72 Asset Management

Boothbay Fund Management

Two Sigma Investments

Geode Capital Management

Tower Research Capital

SHP Wealth Management

View all funds holding Galecto

© 2026 stockzoa - Track 13F-HR Filings for Hedge Funds and Value Investors.

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z